Robert J Baumann

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. ncbi request reprint Behavioral treatment of migraine in children and adolescents
    Robert J Baumann
    Department of Neurology, College of Medicine, University of Kentucky, Lexington, Kentucky 40536 0284, USA
    Paediatr Drugs 4:555-61. 2002
  2. ncbi request reprint Neurosarcoid presents differently in children than in adults
    Robert J Baumann
    Department of Neurology, University of Kentucky, Lexington, Kentucky, USA
    Pediatrics 112:e480-6. 2003
  3. ncbi request reprint Valproate-associated stomatitis
    Melody Ryan
    Department of Neurology, College of Medicine, University of Kentucky, Lexington 40536 0084, USA
    J Child Neurol 17:225-7. 2002
  4. doi request reprint Elastosis perforans serpiginosa, Down syndrome, and moyamoya disease
    Patricio S Espinosa
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0284, USA
    Pediatr Neurol 38:287-8. 2008
  5. ncbi request reprint Stability of salivary concentrations of the newer antiepileptic drugs in the postal system
    Mikael D Jones
    University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536, USA
    Ther Drug Monit 27:576-9. 2005
  6. ncbi request reprint An unusual complication of cancer treatment for acute lymphoblastic leukemia
    Rosario Maria S Riel-Romero
    Department of Neurology, University of Kentucky, College of Medicine, Lexington, Kentucky, USA
    J Neurooncol 73:269-72. 2005
  7. doi request reprint Lack of valproic acid-associated weight gain in prepubertal children
    Patricio S Espinosa
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0284, USA
    Pediatr Neurol 39:177-80. 2008
  8. ncbi request reprint Correlation of levetiracetam concentrations between serum and saliva
    Shellee A Grim
    University of Kentucky Chandler Medical Center, Lexington, USA
    Ther Drug Monit 25:61-6. 2003
  9. ncbi request reprint Physician preference for antiepileptic drug concentration testing
    Robert J Baumann
    Department of Neurology, College of Medicine, University of Kentucky, Lexington, Kentucky 40536 0284, USA
    Pediatr Neurol 30:29-32. 2004
  10. ncbi request reprint Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy
    Robert J Baumann
    University of Kentucky, Lexington KY, USA
    Curr Med Res Opin 23:2461-5. 2007

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Behavioral treatment of migraine in children and adolescents
    Robert J Baumann
    Department of Neurology, College of Medicine, University of Kentucky, Lexington, Kentucky 40536 0284, USA
    Paediatr Drugs 4:555-61. 2002
    ..Behavioral therapies have the potential to do this, giving the child access to a technique that can be easily resumed without a medical visit or prescription...
  2. ncbi request reprint Neurosarcoid presents differently in children than in adults
    Robert J Baumann
    Department of Neurology, University of Kentucky, Lexington, Kentucky, USA
    Pediatrics 112:e480-6. 2003
    ..Neurosarcoid is seldom recognized in children. In the absence of any large pediatric series, it has been assumed that the presenting signs and symptoms are identical in adults and children...
  3. ncbi request reprint Valproate-associated stomatitis
    Melody Ryan
    Department of Neurology, College of Medicine, University of Kentucky, Lexington 40536 0084, USA
    J Child Neurol 17:225-7. 2002
    ..Cessation of the medication was associated with resolution of the stomatitis. A review of the pertinent literature is also provided. Stomatitis is a rare but potentially serious adverse effect of divalproex sodium administration...
  4. doi request reprint Elastosis perforans serpiginosa, Down syndrome, and moyamoya disease
    Patricio S Espinosa
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0284, USA
    Pediatr Neurol 38:287-8. 2008
    ..Development of elastosis perforans serpiginosa in association with progressive vaso-occlusive disease may be a biological marker of progression of moyamoya disease...
  5. ncbi request reprint Stability of salivary concentrations of the newer antiepileptic drugs in the postal system
    Mikael D Jones
    University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536, USA
    Ther Drug Monit 27:576-9. 2005
    ..90, and ZNS rs = 1). Saliva samples mailed by patients maintain stability and can be returned in a reasonable length of time. Further studies are needed to assess patient/caretaker capability of obtaining an adequate sample...
  6. ncbi request reprint An unusual complication of cancer treatment for acute lymphoblastic leukemia
    Rosario Maria S Riel-Romero
    Department of Neurology, University of Kentucky, College of Medicine, Lexington, Kentucky, USA
    J Neurooncol 73:269-72. 2005
    ..We report an 11-year-old child who, as supported by both clinical course and neuroimaging studies, developed an unusual complication eight years after completing therapy for acute lymphoblastic leukemia, gliomatosis cerebri...
  7. doi request reprint Lack of valproic acid-associated weight gain in prepubertal children
    Patricio S Espinosa
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0284, USA
    Pediatr Neurol 39:177-80. 2008
    ..5, P = 0.03). We detected no excessive weight gain for children on valproic acid, whereas this was demonstrated for a similar socioeconomic group on carbamazepine...
  8. ncbi request reprint Correlation of levetiracetam concentrations between serum and saliva
    Shellee A Grim
    University of Kentucky Chandler Medical Center, Lexington, USA
    Ther Drug Monit 25:61-6. 2003
    ..No published data exist for levetiracetam (LEV) to the authors' knowledge. This study's objective is to determine the correlation between LEV serum and saliva concentrations...
  9. ncbi request reprint Physician preference for antiepileptic drug concentration testing
    Robert J Baumann
    Department of Neurology, College of Medicine, University of Kentucky, Lexington, Kentucky 40536 0284, USA
    Pediatr Neurol 30:29-32. 2004
    ..These data suggest that a painless method of measuring antiepileptic drug concentrations--especially if it could be performed at home--would fulfill an unmet need in the care of children with epilepsy...
  10. ncbi request reprint Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy
    Robert J Baumann
    University of Kentucky, Lexington KY, USA
    Curr Med Res Opin 23:2461-5. 2007
    ..We report the utility of a dosing algorithm designed to maintain stable trough lamotrigine (LTG) concentrations during conversion from valproate (VPA) to LTG monotherapy in adolescents aged 16-20 years...
  11. ncbi request reprint Correlation of lamotrigine concentrations between serum and saliva
    Melody Ryan
    University of Kentucky Chandler Medical Center, Lexington 40536 0293, USA
    Pharmacotherapy 23:1550-7. 2003
    ..To compare the relationship between serum and salivary concentrations of lamotrigine in pediatric and adult epilepsy populations...
  12. ncbi request reprint Topiramate concentration in saliva: an alternative to serum monitoring
    Michael V Miles
    Pathology and Laboratory Medicine, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Pediatr Neurol 29:143-7. 2003
    ..8% +/- 12.1% (range 62.9% to 112.7%). The results of this study support the use of saliva as a viable alternative to serum for monitoring topiramate therapy. Topiramate concentration in saliva: an alternative to serum monitoring...
  13. ncbi request reprint Clinical utility of a continuous intravenous infusion of valproic acid in pediatric patients
    Lisa M Taylor
    Department of Pharmacy Services, Shands Hospital at the University of Florida, Florida, USA
    Pharmacotherapy 27:519-25. 2007
    ..To describe the dose-concentration relationship of a continuous intravenous infusion of valproic acid (VPA) in pediatric patients when a dosing protocol is used...
  14. ncbi request reprint Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD)
    Michael V Miles
    Department of Pediatrics, University of Cincinnati Medical Center, and Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Ther Drug Monit 26:300-4. 2004
    ..It is also recommended to avoid saliva collection within 8 hours after OXC dosing to allow complete absorption and transformation of the parent drug...